MRI Assessment of Mode of Action of Bisacodyl, Single Dose
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
MRI Assessment of Mode of Action of Bisacodyl, Multiple Doses
- Status
- COMPLETED
- Phase
- PHASE4
A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)
- Status
- COMPLETED
- Phase
- NA
Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
- Status
- COMPLETED
- Phase
- N/A
Acne Vulgaris Related Microbiology and Serology
- Status
- COMPLETED
- Phase
- N/A
Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- COMPLETED
- Phase
- PHASE1
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Teicoplanin in CDAD
- Status
- TERMINATED
- Phase
- PHASE4
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
North American Acute Coronary Syndrome (ACS) Reflective III Pilot
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- Status
- RECRUITING
- Phase
- N/A
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
- Status
- COMPLETED
- Phase
- PHASE3